Every Form 4 that Copart Inc (CPRT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CPRT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CPRT filings page.
COPART INC (CPRT) reported equity awards to Chief Financial Officer Leah C. Stearns. She received 12,654 Restricted Stock Units, each representing one share of common stock, and 200,000 stock options with a per-share exercise price of $31.61, expiring on August 16, 2036.
The RSUs vest 20% on August 16, 2027, with the remainder vesting quarterly so that all vest by the fifth anniversary. The options vest over five years with time-based vesting; 114,400 of these options also require Copart’s stock to trade at or above $39.51 for twenty consecutive trading days and at exercise to become exercisable.
COPART INC (CPRT) reported that President Jane Pocock received equity awards on August 16, 2026. She was granted 25,308 Restricted Stock Units, each representing one share of common stock, and 500,000 stock options with an exercise price of $31.61 per share. RSUs vest 20% on August 16, 2027, with the remainder vesting quarterly so that all vest by the fifth anniversary. The options vest over five years with time-based vesting and expire in 2036, and 279,000 options also require the stock price to reach at least $39.51 for twenty consecutive trading days before they become exercisable.
COPART INC director David Joel Berger reported an award of 24,341 stock options on August 13, 2026. The options have an exercise price of $29.39 per share and expire on August 13, 2033. They vest on a monthly basis over the 12 months following the grant date under the company’s 2007 Equity Incentive Plan, and Berger now holds 24,341 options directly from this grant.
Copart Inc. Chief Executive Officer Jeffrey Liaw reported option-related transactions dated July 28, 2026. He exercised stock options to acquire 46,757 shares of common stock at strike prices of $6.78 and $8.70 per share, and sold 27,745 shares at $30.49 per share. The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2025. The exercised options came from 2017 and 2018 grants that vested 20% after one year and the remainder monthly over 48 months.
COPART INC Chief Executive Officer Jeffrey Liaw exercised stock options to acquire 2,089 shares of common stock on 2026-07-15 at exercise prices of $6.7800 and $8.7000 per share. These option exercises, executed under a Rule 10b5-1 trading plan, increased his direct common holdings to 80,809 shares and left stock options outstanding for 221,884 and 182,718 underlying shares from earlier grants.
COPART INC director Daniel J. Englander reported indirect transactions in Copart common stock through Ursula Capital Partners. On July 13, 2026, Ursula Capital Partners sold 80,000 shares in open-market transactions at a weighted average price of $27.55 per share, with individual prices ranging from $27.50 to $27.66. On the same date, Ursula Capital Partners also recorded an “other” transaction, distributing 40,000 shares of Copart common stock to its limited partners (excluding Mr. Englander). Footnotes state that Ursula Capital Partners holds 275,352 shares in one line and 235,352 shares in another, all for which Mr. Englander serves as sole general partner.
COPART INC director Diane M. Morefield exercised stock options to acquire 50,000 shares of Common Stock. The options related to the company’s 2007 Equity Incentive Plan and had an exercise price of $19.3775 per share. Following the transactions, she holds 50,000 Common Stock shares directly.
Copart Inc. Chief Executive Officer Jeffrey Liaw exercised stock options and sold shares of common stock. He exercised options covering 49,775 shares of Copart at strike prices of $6.78 and $8.70 per share, converting them into common stock.
On the same date, he sold a total of 26,213 shares of common stock in open-market transactions at weighted average prices of about $33.18 and $33.17 per share, across price ranges from $32.97 to $33.46. Both sales occurred automatically under a Rule 10b5-1 trading plan adopted on April 15, 2025, indicating they were pre-scheduled rather than discretionary trades.
Following these transactions, Liaw directly owned 79,532 shares of Copart common stock reported in this filing, reflecting that he retained a substantial equity position after exercising options and selling a portion of the resulting shares.
Copart, Inc. Executive Chairman A. Jayson Adair reported several indirect transfers of Copart common stock on January 20, 2026, all recorded at $0 per share and coded as transaction type G. The transactions involved 7,761 shares held by the A. Jayson Adair and Tammi L. Adair Revocable Trust and 21,200 shares each in two 2018 irrevocable family trusts.
After these moves, the filing shows indirect beneficial ownership of 14,174,859 shares in the revocable trust, 254,400 shares in Trust A and 318,000 shares in Trust B, plus additional indirect holdings through JTGJ Properties, JTGJ Investments, The Adair Foundation, and JTGJ Investments II. For JTGJ Investments, LP, Adair disclaims beneficial ownership beyond any pecuniary interest.
Copart, Inc. Chief Executive Officer Jeffrey Liaw reported multiple stock option exercises and related share sales. On January 15, 2026, he exercised employee stock options to buy Copart common stock at exercise prices of $6.78 and $8.70 per share, including blocks of 4,523, 43,166, 809 and 1,277 underlying shares. He then sold 2,444 shares at a weighted average price of $40.17 per share and another 22,693 shares at a weighted average price of $40.17 per share. The filing notes these sales occurred automatically under trading plans, including a Rule 10b5-1 plan adopted on April 15, 2025. After the reported transactions, Liaw directly held 55,970 shares of Copart common stock.
Copart, Inc. reported an insider equity award to one of its directors dated 12/05/2025. The filing shows a grant of a stock option covering 17,813 shares of common stock at an exercise price of $38.72 per share, issued under the company’s 2007 Equity Incentive Plan.
The options vest on a monthly basis over the 12 months following the grant date and carry an expiration date of 12/05/2032. After this grant, the director beneficially owns 17,813 stock options directly, and the price of the derivative security is listed as $0.
Copart, Inc. reported that one of its directors received a grant of stock options on 12/05/2025. The Form 4 shows the award of 17,813 stock options with an exercise price of $38.72 per share, each option linked to one share of Copart common stock.
The options were granted under Copart’s 2007 Equity Incentive Plan, carry an expiration date of 12/05/2032, and were reported as directly owned. According to the footnotes, the options vest on a monthly basis over the 12 months following the grant date, meaning the director’s right to exercise the options increases gradually during the year after the grant.
Copart, Inc. (CPRT) director reports an option exercise and share sale. On 11/25/2025, the reporting person exercised stock options for 100,000 shares of Copart common stock at an exercise price of $11.8 per share. On the same date, they sold 100,000 shares of common stock in the open market at a weighted average price of $39.07 per share, with individual sale prices ranging from $39.00 to $39.14. Following these transactions, the reported direct holdings of both the underlying stock options and common shares were 0.
Copart, Inc. director reports stock option exercise on a Form 4. A company director exercised stock options covering 100,000 shares of Copart common stock on 11/13/2025 at an exercise price of $11.80 per share. Following this transaction, the reporting person directly held 100,000 shares of Copart common stock, and the reported stock option position was reduced to zero. The options were originally granted under the company’s 2007 Equity Incentive Plan and had vested monthly over 12 months after the grant date.
Copart (CPRT) CEO reported multiple transactions on 10/15/2025. He exercised employee stock options at $6.78 and $8.70, acquiring common shares in four lots: 809, 1,277, 4,523, and 43,166. He then sold 2,197 shares at a weighted average price of $44.8028 and 22,086 shares at a weighted average of $44.7902.
Both sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2025. Following these transactions, beneficial ownership stood at 31,332 shares held directly.
Copart (CPRT) Executive Chairman and Director A. Jayson Adair filed a Form 4 reporting transactions dated 01/06/2025.
The filing shows three transaction code G entries for common stock, each at a price of $0, reflecting disposals of 5,360, 21,200, and 21,200 shares from indirect holdings.
Following these transactions, indirect beneficial ownership reported includes 14,182,620 shares via the A. Jayson Adair and Tammi L. Adair Revocable Trust, 275,600 shares via the 2018 Willis and Reba Johnson Irrevocable Trust A, and 339,200 shares via The 2018 Willis and Reba Johnson Irrevocable Trust B.